Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Register

Assessment Committee

Ratifies every certainty rating the Institute publishes. Chaired independently of the Board.

Entries

11 documents
  • CEI-RG-015Assessment CommitteeAssessment Committee member, analytical standardssince 2024

    Contributes the analytical-characterisation sections of the monographs and reviews every submitted third-party report for method adequacy. She identified the systematic problem, recorded across several monographs, that…

    Analytical Scientist, accredited testing…
  • CEI-RG-016Assessment CommitteeAssessment Committee member, nephrologysince 2024

    Responsible for renal assessments, including the Institute's convention of reporting annual eGFR slope alongside any composite kidney endpoint on the ground that slope is less vulnerable to competing-risk distortion in…

    Consultant Nephrologist
  • CEI-RG-010Assessment CommitteeDeputy Chair, Assessment Committeesince 2023

    Chairs assessments from which the Committee Chair is recused, which in practice means the entire incretin series. His contribution is the Institute's treatment of trials stopped early for efficacy: they are extracted in…

    Consultant Cardiologist; Reader in…
  • CEI-RG-013Assessment CommitteeAssessment Committee member, safetysince 2024

    Responsible for adverse-event extraction and for the Institute's convention that an incidence figure is reported with the trial, dose and duration from which it comes, never as a bare percentage. She also authored the…

    Consultant in Pharmacovigilance
  • CEI-RG-012Assessment CommitteeAssessment Committee member, clinical pharmacologysince 2023

    Responsible for the pharmacokinetic sections of the monograph series, including the decision to record explicitly where a parameter has not been characterised in humans rather than importing an animal value. He has…

    Clinical Pharmacologist, teaching hospital
  • CEI-RG-017Assessment CommitteeAssessment Committee member, neuropsychiatric outcomessince 2025

    Responsible for assessments in the neuropsychiatric indications, including the addiction and cognition groups. She authored the Institute's distinction between a low certainty rating arising from an absence of studies…

    Consultant Psychiatrist
  • CEI-RG-011Assessment CommitteeLead Statistician, Assessment Committeesince 2023

    Responsible for every effect estimate and confidence interval the Institute reproduces, and for the rule that an estimate is reported on the scale on which it was measured before any standardisation. She insisted that…

    Senior Statistician, independent
  • CEI-RG-018Assessment CommitteeAssessment Committee member, respiratory and sleepsince 2025

    Responsible for the sleep-apnoea assessments and for the observation, recorded in several documents, that centrally scored polysomnographic endpoints support a higher certainty rating than symptom-only respiratory…

    Consultant in Respiratory and Sleep Medicine
  • CEI-RG-019Assessment CommitteeAssessment Committee member, methodssince 2024

    Responsible for the search strategies underlying the synthesis series and for the requirement that every synthesis publish its search strings, database coverage and screening decisions in full, so that a reader can…

    Senior Research Fellow, evidence synthesis
  • CEI-RG-009Assessment CommitteeChair, Assessment Committeesince 2023

    Chairs the committee that ratifies every certainty rating the Institute publishes. Her methodological position, applied consistently across the monograph series, is that an active-controlled non-inferiority result and a…

    Professor of Diabetes and Endocrinology
  • CEI-RG-014Assessment CommitteeAssessment Committee member, chemistrysince 2023

    Responsible for the identification sections of the monograph series. Her rule, applied throughout, is that where a structure has not been published the monograph says "not disclosed" rather than reproducing an unsourced…

    Professor of Medicinal Chemistry
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.